Artiva Biotherapeutics (ARTV) Return on Equity (2024 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Return on Equity for 2 consecutive years, with 0.7% as the latest value for Q4 2025.
- Quarterly Return on Equity fell 38.0% to 0.7% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.7% through Dec 2025, down 38.0% year-over-year, with the annual reading at 0.57% for FY2025, 474.0% up from the prior year.
- Return on Equity for Q4 2025 was 0.7% at Artiva Biotherapeutics, down from 0.57% in the prior quarter.
- The five-year high for Return on Equity was 0.03% in Q2 2024, with the low at 6.59% in Q3 2024.